» Articles » PMID: 10474287

Quality of Life in Low-income Patients with Metastatic Prostate Cancer: Divergent and Convergent Validity of Three Instruments

Overview
Journal Qual Life Res
Date 1999 Sep 4
PMID 10474287
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Few studies have evaluated Quality Of Life (QOL) among low-income patients with cancer. Information is needed about the feasibility and psychometric characteristics of QOL instruments in these populations. The purpose of this study was to examine the convergent and discriminant relationships between scales of three QOL instruments: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC), Functional Assessment of Cancer Therapy--General (FACT), and Quality of Life Index (QLI). Participants included 110 men with metastatic prostate cancer of whom 94% were low income and 62% were African-American. Interviewers administered the questionnaires. Cronbach alpha internal consistency reliabilities were 0.57 to 0.90 for the EORTC, 0.65 to 0.86 for the FACT, and 0.63 for the QLI. Convergent validity was supported for the EORTC and FACT scales measuring emotional, physical, and role/functional dimensions (r = 0.54 to 0.72), but not on scales measuring social function (r = 0.12). Divergent validity was supported between dissimilar scales (r = 0.14 to 0.38). Analysis with receiver operating characteristics curves provided empirical support for the EORTC and FACT as multidimensional measures. These findings suggest that, even in busy clinical settings with low literacy patients, interviewer-administered EORTC and FACT QOL instruments can provide valid and reliable information.

Citing Articles

Reliability and validity of Amharic version of EORTC QLQ-C30 and QLQ-BR23 modules for assessing health-related quality of life among breast cancer patients in Ethiopia.

Gadisa D, Gebremariam E, Ali G Health Qual Life Outcomes. 2019; 17(1):182.

PMID: 31830992 PMC: 6909579. DOI: 10.1186/s12955-019-1257-z.


Measuring health-related quality of life in patients with advanced cancer: a systematic review of self-administered measurement instruments.

van Roij J, Fransen H, van de Poll-Franse L, Zijlstra M, Raijmakers N Qual Life Res. 2018; 27(8):1937-1955.

PMID: 29427216 DOI: 10.1007/s11136-018-1809-4.


Reliability and Validity of Amharic Version of EORTC QLQ-C 30 Questionnaire among Gynecological Cancer Patients in Ethiopia.

Ayana B, Negash S, Yusuf L, Tigeneh W, Haile D PLoS One. 2016; 11(6):e0157359.

PMID: 27304066 PMC: 4909272. DOI: 10.1371/journal.pone.0157359.


Reliability across studies from the functional assessment of cancer therapy-general (FACT-G) and its subscales: a reliability generalization.

Victorson D, Barocas J, Song J, Cella D Qual Life Res. 2008; 17(9):1137-46.

PMID: 18841493 DOI: 10.1007/s11136-008-9398-2.

References
1.
Schag C, Heinrich R . Development of a comprehensive quality of life measurement tool: CARES. Oncology (Williston Park). 1990; 4(5):135-8;discussion 147. View

2.
Landis S, Murray T, Bolden S, Wingo P . Cancer statistics, 1998. CA Cancer J Clin. 1998; 48(1):6-29. DOI: 10.3322/canjclin.48.1.6. View

3.
Fossa S . Quality of life after palliative radiotherapy in patients with hormone-resistant prostate cancer: single institution experience. Br J Urol. 1994; 74(3):345-51. DOI: 10.1111/j.1464-410x.1994.tb16625.x. View

4.
Esper P, Mo F, Chodak G, Sinner M, Cella D, Pienta K . Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology. 1998; 50(6):920-8. DOI: 10.1016/S0090-4295(97)00459-7. View

5.
Sloan J, Loprinzi C, Kuross S, Miser A, OFallon J, Mahoney M . Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol. 1998; 16(11):3662-73. DOI: 10.1200/JCO.1998.16.11.3662. View